A nurse is assessing a 25-year-old patient with beta-thalass… | 마이메르시 MyMerci
마이메르시 — 문제와 상세 해설까지 전부 무료 무료로 시작하기
Adult Health
문제

A nurse is assessing a 25-year-old patient with beta-thalassemia major. Which assessment finding would be most characteristic of this condition?

해설
Beta-thalassemia major causes severe anemia due to defective hemoglobin synthesis, with hemoglobin often below 7 g/dL. Other options (bleeding, elevated WBC, hyperactive bowel sounds) are not characteristic findings.
같은 주제 다음 문제A nurse is assessing a 25-year-old patient with beta-thalassemia major. Which assessment f…

심화 해설


Core Pathophysiology of Beta-Thalassemia Major

To understand the assessment findings in beta-thalassemia major (β-TM), you must first trace the problem to its genetic origin. This condition results from a mutation in the beta-globin gene, leading to a profound deficiency or complete absence of beta-globin chain synthesis. Normally, adult hemoglobin (HbA) is a tetramer composed of two alpha and two beta chains (α2β2). When beta chains are scarce, a critical chain imbalance occurs: unpaired alpha-globin chains accumulate and precipitate within red blood cell (RBC) precursors in the bone marrow. This precipitation triggers oxidative damage and apoptosis, resulting in a process called ineffective erythropoiesis—the bone marrow produces many cells, but most are destroyed before they ever reach the bloodstream. The RBCs that do survive and enter circulation are severely hypochromic and microcytic, and they are quickly hemolyzed in the spleen. This dual pathology of intramedullary destruction and peripheral hemolysis is the engine driving the profound anemia characteristic of β-TM. [1,2]

Why Severe Anemia is the Hallmark Finding

The correct answer identifies severe anemia with hemoglobin levels typically below 7 g/dL. This is not a mild, incidental finding; it is the central, defining clinical feature that dictates the disease course. The research on children with β-TM underscores that these patients are transfusion-dependent from early life to survive, precisely because their endogenous erythropoiesis cannot sustain a viable hemoglobin concentration. The study by Xu et al. specifically examined the relationship between hematological parameters and brain development, highlighting that the chronic, severe anemia is the primary systemic insult that drives multi-organ complications, including the risk of neurocognitive impairment. Without regular transfusions, the hemoglobin would remain at life-threateningly low levels, unable to deliver sufficient oxygen to tissues. [1]

Differentiating from Other Findings

It is crucial to distinguish the primary pathology from secondary complications or unrelated conditions. Let's analyze the distractors:

  • Excessive bleeding and bruising due to low platelets: This is a hallmark of bone marrow failure syndromes (like aplastic anemia) or platelet disorders, not the primary defect in β-TM. While untreated β-TM can lead to massive splenomegaly, which may cause secondary thrombocytopenia from splenic sequestration, the most characteristic and direct assessment finding is the profound anemia itself. The disease is fundamentally a hemoglobinopathy, not a thrombocytopathy. [2]

  • Elevated white blood cell count from frequent infections: Patients with β-TM, particularly those on chronic transfusion therapy, can be susceptible to infections due to iron overload or transfusion-related risks. However, a chronically elevated WBC count is not a direct, characteristic manifestation of the thalassemic process itself. The primary defect is in RBC production and survival.

  • Hyperactive bowel sounds from increased peristalsis: This finding is not directly linked to the core pathology of β-TM. Gastrointestinal symptoms are not a primary clinical feature of the disease's mechanism, making this the least likely characteristic finding.



Clinical and Assessment Implications

When you assess a patient with β-TM, your findings will reflect the consequences of the profound anemia and the body's compensatory attempts. The severe anemia (Hb

임상 시나리오

Clinical Practice Guide: Assessing Anemia in Beta-Thalassemia Major

When assessing a patient with suspected or confirmed beta-thalassemia major, the clinical picture is dominated by severe, life-limiting anemia. This guide outlines the key assessment findings and their underlying pathophysiology to support accurate clinical judgment.

Core Pathophysiology

Beta-thalassemia major stems from a genetic defect causing absent or profoundly reduced beta-globin chain synthesis. The resulting excess of unpaired alpha-globin chains precipitates in erythroid precursors, causing oxidative damage and apoptosis. This leads to two concurrent processes:

  • Ineffective Erythropoiesis: Massive intramedullary destruction of red blood cell precursors. The bone marrow is hypercellular but fails to deliver mature RBCs to the circulation.
  • Peripheral Hemolysis: The few RBCs that survive are hypochromic and microcytic, with rigid membranes that are prematurely destroyed in the spleen.

Characteristic Assessment Findings

The hallmark finding is severe anemia, typically with hemoglobin levels below 7 g/dL. This is not a subtle sign but the central clinical feature driving the need for lifelong transfusion therapy. Associated findings include:

  • Pallor and Fatigue: Direct consequences of critically low oxygen-carrying capacity.
  • Frontal Bossing and Maxillary Hyperplasia: Result from massive bone marrow expansion in the skull and facial bones due to ineffective erythropoiesis, creating a characteristic "chipmunk facies."
  • Hepatosplenomegaly: The spleen enlarges from extramedullary hematopoiesis and sequestration of abnormal RBCs; the liver may enlarge from iron overload and extramedullary hematopoiesis.
  • Growth Retardation: Chronic anemia and high metabolic demand impair normal development in children.

Differentiating from Other Conditions

It is critical to distinguish this anemia from other causes. Bleeding and bruising (thrombocytopenia) are not primary features; they suggest bone marrow failure syndromes or platelet disorders. Elevated white blood cell counts are not characteristic unless the patient has undergone splenectomy, which can cause a transient leukocytosis. Nonspecific gastrointestinal signs like hyperactive bowel sounds do not correlate with the disease process.

Nursing Assessment Priorities

  • Monitor hemoglobin and hematocrit levels regularly, noting trends toward transfusion thresholds (often Hb

핵심 개념

  • Beta-thalassemia major — A severe inherited blood disorder caused by mutations in the beta-globin gene, resulting in absent or markedly reduced beta-globin chain synthesis and profound, transfusion-dependent anemia.
  • Ineffective erythropoiesis — A process where erythroid precursor cells in the bone marrow are destroyed before they mature into functional red blood cells, a key mechanism of anemia in beta-thalassemia major.
  • Hemoglobinopathy — A group of genetic disorders characterized by abnormal structure or production of the hemoglobin molecule, including thalassemias and sickle cell disease.
  • Hypochromic microcytic anemia — A type of anemia where red blood cells are paler than normal (hypochromic) and smaller than normal (microcytic), typically due to defects in hemoglobin synthesis.
  • Hemolysis — The premature destruction of red blood cells, which in beta-thalassemia major occurs primarily in the spleen and contributes to the severe anemia.
Merci NCLEX-RN Question Bank 3,445 문제 · 로그인 없이 바로 볼 수 있어요

마이메르시로 국가고시 완벽 대비

기출문제와 상세 해설을 무료로. 내 약점을 분석하고 진도를 관리하며 더 똑똑하게 공부하세요.

무료로 시작하기
App Store Google Play

학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.